Christophe Homer
Director of Intelligence Hanson Wade Intelligence
Seminars
Wednesday 1st April 2026
CDx Partnership, Changing Needs & Dynamics of Drug Developers & CDx Service Provider Collaborations
12:50 pm
- Existing challenges: As drug development becomes more heavily invested in precision medicine, being able to identify and develop the optimal biomarker strategy for development, clinical trial and launch has never been more critical
- Needs alignment: A fundamental starting point is to understand the existing alignments and disconnects between drug development needs and CDx partner capabilities
- Shaping the future: The future evolution of needs, relationships and strategy will not only impact the success of assets, but businesses themselves
